by Industry

Life Sciences

"SAS Drug Development integrates a number of key capabilities into a single, compliance-enabling solution for managing, analyzing and exploring clinical data," said Judy Hanover, senior research director for IDC's Life Science Insights. "By making the research content from locations across the organization available to trial managers, clinicians and biostatisticians, and embedding tools designed for each type of user, SAS Drug Development provides a unique offering to the life sciences research industries companies. When SAS Drug Development is used in conjunction with data from third-party sources like EDC, laboratory and safety systems, users can conduct the statistical analysis required for techniques like adaptive trials, signal detection and pharmacovigilance.”
– SAS News Release, "SAS^® Drug Development sets the standard for clinical trials information management and analysis," April 11, 2005
(Judy Hanover, Senior Research Analyst, IDC Life Science Insights)